Correlation Between DiaMedica Therapeutics and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Tempest Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Tempest Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Tempest Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between DiaMedica and Tempest is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Tempest Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.49 times more return on investment than Tempest Therapeutics. However, DiaMedica Therapeutics is 2.06 times less risky than Tempest Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 438.00 in DiaMedica Therapeutics on August 24, 2024 and sell it today you would lose (20.00) from holding DiaMedica Therapeutics or give up 4.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Tempest Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Tempest Therapeutics |
DiaMedica Therapeutics and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Tempest Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Tempest Therapeutics vs. Lyra Therapeutics | Tempest Therapeutics vs. Hookipa Pharma | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |